Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
36.68
+0.58 (1.61%)
At close: Jun 8, 2026, 4:00 PM EDT
36.68
0.00 (0.00%)
After-hours: Jun 8, 2026, 4:10 PM EDT
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.75 billion as of June 8, 2026. Its market cap has increased by 378.75% in one year.
Market Cap
1.75B
Enterprise Value
1.29B
1-Year Change
378.75%
Ranking
Category
Stock Price
$36.68
Market Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.75B, an increase of 191.70%. That is a compound annual growth rate of 71.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 1.73B | 19.40% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vericel | 1.82B |
| Stoke Therapeutics | 1.81B |
| Nanobiotix | 1.80B |
| Ocular Therapeutix | 1.79B |
| Iovance Biotherapeutics | 1.79B |
| Recursion Pharmaceuticals | 1.76B |
| Zymeworks | 1.75B |
| Viridian Therapeutics | 1.74B |